Global Anticoagulant Reversal Drugs Market By Product (Vitamin K Antagonists, Prothrombin Complex Concentrates (PCC), Fresh Frozen Plasma (FFP), Protamine Sulfate, Idarucizumab, Andexanet Alfa and Others), By Indication (Bleeding, Perioperative/Pre Surgical Reversal and Supratherapeutic Drug Levels), By Route of Administration (Intravenous, Subcutaneous and Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
- Published date: Dec 2025
- Report ID: 171923
- Number of Pages: 272
- Format:
-
keyboard_arrow_up
-
-
- Pfizer Inc.
- AstraZeneca
- CSL Behring Limited
- Octapharma AG
- Dr. Reddy’s Laboratories
- Teva Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Mylan N.V.
- Novartis AG
- Lupin Ltd.
- Cipla Inc.
- Endo International plc
- Amneal Pharmaceuticals, Inc.
Our Clients
Kickstart 2026 with Exclusive Savings
✖
Request a Sample Report
We'll get back to you as quickly as possible